€22.66 COP.DE CompuGroup Medical XETRA Market Closed 29 Jan 2026: Oversold bounce opportunity
Today CompuGroup Medical (COP.DE) closed on XETRA at €22.66, up 1.07% on the session and trading above its 50-day average. COP.DE stock shows a short-term oversold bounce pattern after heavy selling in prior months. Volume was elevated at 145,385 shares versus a 50,000-range average, signalling renewed buyer interest. We examine the technical trigger, relevant fundamentals, and where analysts and our models see price heading for Germany-listed CompuGroup Medical
Price action and immediate technical setup for COP.DE stock
COP.DE stock closed €22.66 on XETRA with a daily range of €22.28–€23.36. The share has a 52-week high of €23.84 and low of €13.10. Volume at 145,385 was roughly three times average, underlining the intraday bounce.
Short-term indicators show the stock trading above its 50-day average (€22.14) and above the Keltner middle band (€22.66). That makes today’s move a classic oversold bounce: heavy prior selling followed by volume-backed buying. Traders looking for mean-reversion can watch €24.00 resistance and support at €20.50.
Fundamentals snapshot: valuation and cash flow
CompuGroup Medical reported EPS €0.52 and trades at a current PE near 43.58 based on the latest quote. Market capitalisation stands at about €1.17B and shares outstanding are 51,734,600. The company generates solid operating cash flow per share of €2.89 and free cash flow per share of €2.04.
Balance-sheet metrics show debt pressure with a debt-to-equity ratio near 1.27 and net debt to EBITDA elevated. Price-to-sales is 1.33 and price-to-book is 1.80, placing COP.DE stock below some healthcare software peers on absolute multiples but above sector averages on earnings yield.
Sector context and why the bounce matters in Healthcare
Healthcare software stocks on XETRA trade at an average PE near 33.50, so COP.DE stock’s current valuation sits above the sector earnings multiple. The company operates across AIS, PCS, HIS, and CHS segments, which gives diversified revenue exposure to both ambulatory and hospital IT demand.
Sector flows matter: Healthcare performance has been flat year-to-date and lower-beta relative to Technology. An oversold bounce in COP.DE could attract sector rotation funds seeking defensive growth names with software revenue streams.
Meyka AI grade and model forecast for COP.DE stock
Meyka AI rates COP.DE with a score out of 100: 63.99 | Grade: B | Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus.
Meyka AI’s forecast model projects a base case €26.50, upside case €30.00, and downside case €18.00 versus the current €22.66. That implies a base-case upside of 16.92%, upside case of 32.44%, and downside risk of -20.53%. Forecasts are model-based projections and not guarantees.
Catalysts, risks, and what to watch next
Near-term catalysts include the next earnings release and contract rollouts in hospital IT and pharmacy systems. Positive contract news could validate the oversold bounce and push price toward resistance at €24.00–€26.50.
Key risks are leverage and margin pressure. The company’s interest coverage is around 3.02, and net debt to EBITDA is elevated. Watch receivables days near 100 and free cash flow trends for signs of operational strain.
Final Thoughts
Key takeaways on COP.DE stock: the share closed €22.66 on XETRA on 29 Jan 2026 with heavy relative volume, forming a textbook oversold bounce. Fundamentals show positive cash generation with an EPS of €0.52, but valuation is stretched on some metrics with a PE near 43.58. Meyka AI’s model gives a base target of €26.50 (+16.92%), a bullish case of €30.00 (+32.44%), and a downside at €18.00 (-20.53%). Traders seeking a tactical oversold bounce can scale in near €21.00–€22.00 with tight stops below €20.50. Investors focused on fundamentals should monitor leverage and cash flow, since higher debt raises downside risk despite recurring software revenue. Meyka AI, an AI-powered market analysis platform, flags COP.DE as a HOLD by grade, not as investment advice. For further company details and live tools visit the COP.DE page on Meyka. For sector context see MarketBeat and Investing.com coverage source and source. Forecasts are model-based projections and not guarantees.
FAQs
Is COP.DE stock a buy after the oversold bounce?
COP.DE stock shows a short-term oversold bounce, but Meyka AI rates it B (HOLD). Consider entry near €21.00–€22.00 with risk limits. Watch leverage and cash flow before adding weight.
What are realistic price targets for COP.DE stock?
Meyka AI’s model projects a base target of €26.50, a bullish case of €30.00, and a downside at €18.00. These imply +16.92%, +32.44%, and -20.53% versus €22.66.
Which metrics matter most when watching COP.DE stock?
Key metrics are EPS €0.52, PE near 43.58, free cash flow per share €2.04, debt-to-equity 1.27, and days sales outstanding around 100. Monitor earnings and cash flow trends.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
